Literature DB >> 18501029

Guidelines for asthma management: a review and comparison of 5 current guidelines.

Timothy R Myers1.   

Abstract

The first clinical practice guidelines for the assessment and management of asthma were published over 20 years ago in New Zealand and Australia. During the same period, British and Scottish groups were collaborating on a United Kingdom version of asthma guidelines. Shortly after the introduction of the New Zealand and Canadian guidelines, the National Heart, Lung, and Blood Institute of the United States National Institutes of Health participated in 2 additional asthma guideline endeavors, which were published in the early 1990s. The National Heart, Lung, and Blood Institute formed the National Asthma Education and Prevention Program to develop asthma guidelines for the United States, and participated with an international task force to develop guidelines for the treatment of asthma in all countries, which resulted in the formation of the Global Initiative for Asthma in the mid-1990s. The asthma guidelines issued by professional societies and other groups prior to the late 1990s were primarily based on consensus or expert opinion in each guideline committee, though those opinions were based on the available studies. The early guidelines played a vital role in bridging the gap between various treatment options and recent discoveries in basic science, and served as the vehicle to implementation into daily clinical practice. Asthma guidelines have been published and revised in dozens of countries around the world and have become reputable directives or "road maps" in asthma diagnosis, treatment, and management for patients of all ages. The guidelines have similar formats. The dissemination and implementation of the early guidelines was inconsistent, and they were criticized for not being evidence-based. As the knowledge of asthma pathophysiology continues to expand, along with basic science research on asthma diagnosis, treatment, and management, as well as education of the asthma patient, it is essential that the asthma guidelines be frequently updated and based on evidence-based-medicine processes.

Entities:  

Mesh:

Year:  2008        PMID: 18501029

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  18 in total

1.  Quantitative analysis of dynamic airway changes after methacholine and salbutamol inhalation on xenon-enhanced chest CT.

Authors:  Sang Joon Park; Chang Hyun Lee; Jin Mo Goo; Jong Hyo Kim; Eun-Ah Park; Jae-Woo Jung; Heung-Woo Park; Sang-Heon Cho
Journal:  Eur Radiol       Date:  2012-06-27       Impact factor: 5.315

Review 2.  History of guidelines for the diagnosis and management of asthma: from opinion to control.

Authors:  Claus Kroegel; Hubert Wirtz
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

Review 3.  Assessing the risks and benefits of step-down asthma care: a case-based approach.

Authors:  John B Hagan; Matthew A Rank
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

Review 4.  Anticholinergics/antimuscarinic drugs in asthma.

Authors:  Xavier Soler; Joe Ramsdell
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

5.  A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung.

Authors:  Gloria S Forkuo; Amanda N Nieman; Revathi Kodali; Nicolas M Zahn; Guanguan Li; M S Rashid Roni; Michael Rajesh Stephen; Ted W Harris; Rajwana Jahan; Margaret L Guthrie; Olivia B Yu; Janet L Fisher; Gene T Yocum; Charles W Emala; Douglas A Steeber; Douglas C Stafford; James M Cook; Leggy A Arnold
Journal:  Mol Pharm       Date:  2018-04-02       Impact factor: 4.939

6.  MIDD0301 - A first-in-class anti-inflammatory asthma drug targets GABAA receptors without causing systemic immune suppression.

Authors:  Nicolas M Zahn; Alec T Huber; Brandon N Mikulsky; Mae E Stepanski; Alexander S Kehoe; Guanguan Li; Melissa Schussman; Mohammed S Rashid Roni; Revathi Kodali; James M Cook; Douglas C Stafford; Douglas A Steeber; Leggy A Arnold
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-02-21       Impact factor: 4.080

7.  Resource utilization after introduction of a standardized clinical assessment and management plan.

Authors:  Kevin G Friedman; Rahul H Rathod; Michael Farias; Dionne Graham; Andrew J Powell; David R Fulton; Jane W Newburger; Steven D Colan; Kathy J Jenkins; James E Lock
Journal:  Congenit Heart Dis       Date:  2010 Jul-Aug       Impact factor: 2.007

8.  Efficacy of an in-home test kit in reducing dust mite allergen levels: results of a randomized controlled pilot study.

Authors:  Amber K Winn; Päivi M Salo; Cynthia Klein; Michelle L Sever; Shawn F Harris; David Johndrow; Patrick W Crockett; Richard D Cohn; Darryl C Zeldin
Journal:  J Asthma       Date:  2015-08-24       Impact factor: 2.515

9.  Potential therapy of Fc-antigen combination-encoding DNA vaccination in mouse allergic airway inflammation.

Authors:  Y Wang; G Qian; G Wang; X Cheng; C Bai; X Wang
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

10.  A short-term educational program improved physicians' adherence to guidelines for COPD and asthma in Shanghai.

Authors:  Xiaocong Fang; Shanqun Li; Lei Gao; Naiqing Zhao; Xiangdong Wang; Chunxue Bai
Journal:  Clin Transl Med       Date:  2012-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.